Latest From Biotech Now

Innovate the Four ‘D’s When Pushing Forward Vaccine Development

vaccines

The vaccine market is surging. From next-generation illness fighters in developed countries to treatment vaccines that combat infectious diseases throughout emerging regions, technological advances in this space and strategies to develop better existing vaccines as well as new products are in high demand. Seasoned vaccine experts speaking at a vaccines panel session at the 2011 BIO International Convention shared with attendees a significant golden rule to follow: In order to ensure success, innovation is required Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Profiling Cuban Biotechnology

Yali Friedman, BIO Official Blogger from the BIOtechBlog, will be giving a brief talk on the Cuban Biotechnology industry during a panel at the 2011 BIO International Convention today.  What: Cuban Biotechnology: An Overview of Cuba’s Drug and Vaccine Developments and Innovations When: 2:00 – 2:45pm Where: Room 145B Who: Elaine Scheye, Yali Friedman, Halla Thortsteinsdottir, Pedro Freyre I will be largely citing papers published in the Journal of Commercial Biotechnology and providing a brief overview and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Diversity Summit Reveals Ways Biotech Can Better Integrate Diverse Populations

Chandra Marsono

Dr. Augustus White, III, author of Seeing Patients: Unconscious Bias in Health Care and a pioneer in equitable care delivered the  keynote address at this year’s Diversity Summit at the 2011 BIO International Convention in Washington, D.C. The Summit brought together an esteemed panel of speakers to discuss integrating diverse and underserved populations with the medical, agricultural, and energy research industries.  Panelists included Freda C. Lewis-Hall, M.D., Executive Vice President and Chief Medical Officer at Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

A Center for Advancing Translational Science can spur new therapies

Dr. Francis Collins

Sometimes, spurring the development of new drugs and therapies can be like trying to a cross shark-infested water without a bridge, Dr. Francis Collins, director of NIH, said during his keynote at the Translational Research Forum during the 2011 BIO International Convention. However, during a time of unprecedented scientific advances, but increasingly limited resources, the public and private sectors must learn to combine their respective efforts to relieve human suffering. Dr. Collins gave a rapid Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Gov. backing required for biotechnologies to meet development challenges

Seedling

“We have to push through our policy barriers in order to continue supporting the economic growth of our rural economies in the United States and around the world.” The sentiment behind that statement made by BIO’s President and CEO Jim Greenwood was shared by the speakers and attendees at today’s Leadership Summit which took place at the 2011 BIO International Convention.  The participants addressed the economic obstacles and environmental impacts for biotechnologies in transforming how Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,